Matt Hancock gives speech at the Jenner Institute

The transcript highlights the crucial role of the MHRA and other vaccine heroes in regulating vaccines during the pandemic. Under June Rain's leadership, the MHRA has been a global model for regulation, emphasizing speed and safety. The NHRA's dynamic and independent approach has facilitated scientific progress. Innovative processes like rolling reviews have expedited clinical trials without compromising scrutiny. The MHRA's work provides the UK with a competitive advantage and serves as a learning model for global regulators.

What is one of the key characteristics of the MHRA as described in the first section?

• It is heavily influenced by political decisions.

• It primarily focuses on financial gains.

• It is known for its slow and bureaucratic processes.

• It is dynamic and flexible in its regulatory approach.

How does the MHRA ensure a faster regulatory process without compromising safety?

• By outsourcing the review process to other countries.

• By skipping certain trial phases.

• By using a rolling review process for clinical trials.

• By reducing the number of required trials.

What is the main advantage of the MHRA's rolling review process?

• It allows for immediate market release of vaccines.

• It eliminates the need for clinical trials.

• It shortens the time needed for regulatory approval.

• It reduces the cost of vaccine development.

What competitive advantage does the UK gain from the MHRA's regulatory practices?

• A reputation for having the fastest approval times globally.

• A strong position in global regulatory innovation.

• A monopoly on vaccine production.

• Increased financial investments in healthcare.

How are other global regulators responding to the MHRA's practices?

• They are adopting completely different approaches.

• They are ignoring the MHRA's methods.

• They are looking to learn from the MHRA's innovative practices.

• They are criticizing the MHRA for being too lenient.